News Articles October 2024

New acromegaly drug on the horizon

A new drug for treatment and long-term maintenance therapy for acromegaly is now on the horizon. Crinetics Pharmaceuticals recently submitted its first new drug application (NDA) to the U.S. Food and Drug Administration for paltusotine, which is a once-daily oral selectively-targeted somatostatin receptor type 2 nonpeptide agonist.

Crinetics says researchers used data from from 18 clinical trials in the application, including two Phase 3 trials that evaluated paltusotine for acromegaly in medically untreated and treated patients.   Patients tolerated the treatment well, the medication achieved biochemical control by maintaining IGF-1 levels and improved patients’ symptoms compared to placebo.   The company says it expects to hear back from the FDA by December.

Paltusotine, is the first drug of its type to complete Phase 3 clinical development for acromegaly and is now in Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors.  Read the company’s press release here. 

 

Can machine learning to predict hormone deficiency after pituitary surgery?

A study featured on Nature.com used machine learning algorithms to predict whether patients would develop arginine vasopressin deficiency after transsphenoidal surgery to remove a pituitary adenoma. Read more here: https://www.nature.com/articles/s41598-024-72486-w

 

Pituitary apoplexy strikes groom on wedding day

An article in People.com tells the story of a groom in England who had to leave his wedding reception early due to a severe headache – one that turned out to be a hemorrhaging pituitary tumor. Read more here: https://people.com/groom-migraine-wedding-day-tumor-popped-8718083

 

Researchers try to make synthetic oxytocin for pain relief

An article in the Focus.news looks at efforts to replicate the hormone oxytocin in the lab – in an effort to develop a painkiller that would be safer than opioids. Read more here: https://www.thefocus.news/lifestyle/scientists-are-hoping-to-replicate-the-cuddle-hormone-for-healthy-long-term-pain-relief/

News Articles September 2024

Musician battles craniopharyngioma

An Irish DJ and music producer with the group Bicep named Matt McBriar is recovering after surgery for a large craniopharyngioma.  Read more: https://www.msn.com/en-us/health/other/bicep-s-matt-mcbriar-treated-for-large-and-pretty-rare-brain-tumour/ar-AA1oLDvU?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1

Social media obsession with “cortisol face” masks true pituitary origin

The term “cortisol face” is sweeping social media, with influencers claiming that stress causes high cortisol levels and leads to puffy cheeks, or “moon facies” that can  be treated with diet, creams or lifestyle changes. But doctors say this is misinformation – and true moon facies come from a pituitary disorder. Read more: https://athletechnews.com/cortisol-face/

New study challenges link between cadaver growth hormone and Alzheimer’s

A new study raises objections to past research that linked cadaver-derived human growth hormone with Alzheimer’s disease.  Read more: https://www.thetransmitter.org/alzheimers-disease/skeptics-challenge-claims-of-alzheimers-disease-transmission-via-growth-hormone/

Pituitary story: At ten years old, 6’3” boy battles gigantism

A story in the Daily Mail recounts the case of a ten-year-old boy from the U.K. names Jayson who stands 6’3” tall and battles pituitary gigantism. Read more: https://www.dailymail.co.uk/femail/article-13489681/rare-condition-harsh-realities-tallest-kid-world.html

Pituitary story: 62-year-old Indian man undergoes transsphenoidal surgery

An article in City Air news looks at the case of a man in India who had transnasal transsphenoidal surgery to remove a pituitary tumor. Read more:

https://www.cityairnews.com/content/doctors-remove-complex-brain-tumor-in-62-yr-old-man-through-nasal-route-restore-his-vision

News Articles August 2024

Pituitary story: Rare 7 cm Pituitary Macroadenoma

A story on The Health Site.com looks at the case of a 63-year-old woman in India who underwent transnasal transsphenoidal surgery to remove a 7 centimeter long pituitary macroadenoma. Read more here: https://www.thehealthsite.com/diseases-conditions/rare-large-tumor-removed-from-63-year-old-womans-pituitary-gland-1111633/

Spontaneous remission of Cushing’s in 14-year-old

A story in Cushing’s Disease News looks at the case of a 14-year-old South American girl with Cushing’s, whose disease went into remission after pituitary apoplexy. Read more: https://cushingsdiseasenews.com/news/rare-case-spontaneous-remission-cushings-disease-reported/

Schizophrenia and a Partially-Empty Sella

An article in Cureus looks at the case of a man whose schizophrenia worsened after 20 years, leading to the discovery of a partially empty sella. Read more: https://www.cureus.com/articles/267874-a-case-report-of-schizophrenia-with-a-partially-empty-sella-related-or-incidental#!/

Once-a-month injectable for acromegaly well-tolerated

The once-monthly octreotide subcutaneous depot finished a 52-week long-term safety study. Researchers found that patients tolerated the drug well and that the drug is was safe and boosted biochemical control. Read more: https://www.medpagetoday.com/endocrinology/growthdisorders/111212

 

News Articles July 2024

Hormonal Disruptions and Pituitary Tumors

An endocrinologist in India discusses the hormonal disruption experienced by pituitary patients. Read more: https://www.hindustantimes.com/lifestyle/health/hormonal-disruptions-caused-by-pituitary-tumours-endocrinologist-shares-insights-101718974544057.html

Novel Cushing’s Treatment in Phase 2 Trials

The pharmaceutical company Lundbeck  is now in Phase 2 clinical trials to assess a “potential first-in-class” treatment for Cushing’s disease called LuAG13909. Read more:

https://cushingsdiseasenews.com/news/possible-first-in-class-cushings-disease-treatment-being-tested-phase-2-trial/

Pain in Men vs Women: The Role of Hormones

An article in Very Well Health looks at a study on how pain is produced and felt in women versus men. The researchers found that the hormone prolactin lowered the threshold to activate specialized sensory cells called nociceptors in female cells but did not in male cells.   However the neuropeptide  orexin B had the opposite effect. This could have implications for pain management, as women make up a large percentage of patients seeking treatment for pain. Read more:

https://www.verywellhealth.com/women-and-men-have-differences-in-pain-production-8665947

Hormonal Disruptions and Pituitary Tumors

An endocrinologist in India discusses the hormonal disruption experienced by pituitary patients. Read more: https://www.hindustantimes.com/lifestyle/health/hormonal-disruptions-caused-by-pituitary-tumours-endocrinologist-shares-insights-101718974544057.html

 

 

News Articles June 2024

Can machine learning improve diagnosis of hormone imbalance?

A study in the journal Academic Radiology looks at the use of machine learning to analyze pituitary MRI images (radiomics) and clinical data – and finds it is helpful in the diagnostic process to differentiate between growth hormone deficiency and idiopathic short stature.  Read more: https://www.academicradiology.org/article/S1076-6332(24)00293-9/abstract

Personality changes after pituitary surgery

An article in Medical News Today looks at the personality changes patients can experience after undergoing pituitary surgery. They include mood shifts, depression, anxiety, irritability, aggression, confusion and apathy. Read more:

https://www.medicalnewstoday.com/articles/personality-changes-after-pituitary-surgery#personality-changes

Study: 80% remission rate after 2nd Cushing’s surgery

An article in Cushing’s Disease News looks at a study from the journal Pituitary that found that 80% of patients who had a second surgery for Cushing’s Disease achieved remission. Read more: https://cushingsdiseasenews.com/news/remission-most-cushings-patients-after-2nd-pituitary-surgery/

North Carolina Congressman battles pituitary tumor

Congressman Greg Murphy from North Carolina will be undergoing surgery to remove a pituitary macroadenoma. Dr. Murphy is also a urologist. Read more: https://www.13newsnow.com/article/news/local/north-carolina/outer-banks/congressman-greg-murphy-surgery-brain-tumor-nc-obx/291-2dc18304-d151-426e-b792-6ef74b18708c

Ohio stuntman fights acromegaly, jumps cars

An Ohio news station featured the story of Raymond Kohn, who jumps the General Lee car over big ramps at stunt shows as part of the Northeast Ohio Dukes. But there’s a twist – Kohn is also battling acromegaly and had transsphenoidal surgery to remove the tumor. Watch the story: https://www.wfmj.com/clip/15470193/warren-stunt-driver-overcomes-brain-tumor

 

More Articles

Available Now!

The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Xeris Pharmaceuticals is valued member of the PNA

If you are a nurse or medical professional, register for PNA CEU Membership and earn CEU credits to learn about the symptoms, diagnosis and treatment options for patients with pituitary disorders. Help PNA reduce the time it takes for patients to get an accurate diagnosis.

For more information click here!

PNA Gratefully Acknowleges Our Supporters